See All Slides - tctmd.com

Slides

Presentation TCT 2012

The Future of Surgical VADs

Presenter: William Cohn

October 24, 2012

Presentation TCT 2012

The Clinical Use of Renal Denervation Is Already Expanding Beyond Trial Indications: Insights from the German GREAT Registry

Presenter: Felix Mahfoud

October 24, 2012

Presentation TCT 2012

V2 (Vessix Vascular)

Presenter: James Margolis

October 24, 2012

Presentation TCT 2012

Impact of Completeness of Revascularization on Long-Term Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus: Results from the Bypass Angioplasty...

Presenter: Frederick Feit

October 24, 2012

Presentation TCT 2012

FIM Evaluation of a New Spiral Multielectrode RF Catheter (Medtronic)

Presenter: Martin Rothman

October 24, 2012

Presentation TCT 2012

"Six-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents: The Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting...

Presenter: Hyeon-Cheol Gwon

October 24, 2012

Presentation TCT 2012

TAVR Trends in Europe and What to Expect in the Future

Presenter: Rhonda Robb

October 24, 2012

Presentation TCT 2012

Case 3: IVUS Guided Stenting in Calcified Disease

Presenter: Rainer Hoffmann

October 24, 2012

Presentation TCT 2012

Case 4: Complex PCI Through the Transradial Approach(2)

Presenter: Seung-Whan Lee

October 24, 2012

Presentation TCT 2012

Case Presentation 2: Example of Abuse of AUC

Presenter: Ajay Kirtane

October 24, 2012

Advertisement

Slides

The Future of Surgical VADs

The Clinical Use of Renal Denervation Is Already Expanding Beyond Trial Indications: Insights from the German GREAT Registry

V2 (Vessix Vascular)

Impact of Completeness of Revascularization on Long-Term Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus: Results from the Bypass Angioplasty...

FIM Evaluation of a New Spiral Multielectrode RF Catheter (Medtronic)

"Six-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents: The Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting...

TAVR Trends in Europe and What to Expect in the Future

Case 3: IVUS Guided Stenting in Calcified Disease

Case 4: Complex PCI Through the Transradial Approach(2)

Case Presentation 2: Example of Abuse of AUC

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content